Análise da equidade da política nacional de medicamentos no período de 1998 a 2013

• Ano de defesa: 2016
• Autor(a) principal: Lopes, Flávia Alice Dias
• Orientador(a): Fahel, Murilo Cássio Xavier
• Banca de defesa: Ferreira Júnior, Sílvio, Salim, Celso Amorim
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Fundação João Pinheiro
• Programa de Pós-Graduação: Programa de Mestrado em Administração Pública
• Departamento: Escola de Governo Professor Paulo Neves de Carvalho
• País: Brasil
• Palavras-chave em Português: Saúde pública; Política de saúde; Acesso à saúde; Assistência farmacêutica; Sistema Único de Saúde (Brasil); Política Nacional de Medicamentos
• Área do conhecimento CNPq: ADMINISTRACAO PUBLICA::POLITICA E PLANEJAMENTO GOVERNAMENTAIS
• Link de acesso: http://repositorio.fjp.mg.gov.br/handle/tede/350

Equitable access to medicines is a central strategy for reducing inequalities in healthcare systems, especially in developing countries that still face high levels of socioeconomic disparities such as Brazil. Considering that Brazil's 1988 Constitution defined health as a universal right and the legislation defined the goal to promote equitable access to drugs as a way to ensure a comprehensive healthcare in the public healthcare system, this study aimed to present an overview of equity in financing and access to medicines in Brazil. The literature review indicated that the vertical inequity remain relevant in medicine financing in Brazil, which is the main health expenditure among the poorest households. Moreover, it was found that out-of-pocket expenditure with medicines is strongly associated with the risk of catastrophic expenditure in Brazil. In this scenario, this study analyzed the distribution of access to prescribed drugs and drugs for chronic diseases between population groups with different socioeconomic and demographic characteristics in the period 1988-2013, based on national surveys conducted the Brazilian Institute of Geography and Statistics. Under this approach, it was observed that since the implementation of the National Medicine Policy, in 1998, there was a substantial expansion of the coverage of the free supply of medicines in Brazil, which went from 27.2% in 1998 to 46% in 2008. In addition, it was found that coverage of the free supply of prescribed drugs and drugs for chronic diseases was higher among population groups considered vulnerable, such as non-white, illiterate, living in the rural areas, without private health insurance and lower per capita income, especially among people with poorer health status. This finding indicates that the National Medicine Policy has significant potential to promote horizontal equity in access to medicines, acting as a counterweight to the existing socio-economic disparities in Brazilian society, in an attempt to alleviate the cycle of inequalities in health. com amostras mais amplas. Esse estudo de caso das AGEIs demonstrou que, segundo a percepção dos respondentes, as AGEIs possuem um conjunto de fatores condicionantes favoráveis ao ambiente inovador no setor público.